Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Advanced Drug Delivery Reviews|March 4, 2022
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug deliveryMan Kyu Shim, Suah Yang, In-Cheol Sun, et al.
Biomedicines|May 27, 2026
Functionalized Lipid Nanoparticles for Targeted RNA Delivery in Immune and Inflammatory DiseasesYeongji Jang, Hyun Kyu Song, Man Kyu Shim, et al.
Pharmaceutics|February 25, 2023
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer ImmunotherapyYujeong Moon, Seong Ik Jeon, Man Kyu Shim, et al.
Nanoscale|January 12, 2026
Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinantsDongwon Shin, Jiwoong Choi, Byeongmin Park, et al.
Pharmaceutics|April 23, 2022
Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical TranslationHanhee Cho, Seong Ik Jeon, Cheol-Hee Ahn, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic CancerIn Kyung Cho, Man Kyu Shim, Wooram Um, et al.
Biomaterials|February 14, 2023
In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapyHanhee Cho, Seong Ik Jeon, Man Kyu Shim, et al.
Expert Opinion on Drug Delivery|May 23, 2022
Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapyMan Kyu Shim, Su Kyung Song, Seong Ik Jeon, et al.
Advanced Drug Delivery Reviews|September 1, 2023
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challengesJong Won Lee, Man Kyu Shim, Hyosuk Kim, et al.
Pharmaceutics|April 28, 2023
Adoptive Transfer of Photosensitizer-Loaded Cytotoxic T Cells for Combinational Photodynamic Therapy and Cancer Immuno-TherapyAndré-René Blaudszun, Woo Jun Kim, Wooram Um, et al.
Pageof 7